Edition:
United Kingdom

Mabion SA (MABP.WA)

MABP.WA on Warsaw Stock Exchange

112.00PLN
21 Sep 2018
Change (% chg)

0.80zł (+0.72%)
Prev Close
111.20zł
Open
112.00zł
Day's High
112.00zł
Day's Low
111.00zł
Volume
1,644
Avg. Vol
8,018
52-wk High
139.00zł
52-wk Low
88.21zł

Chart for

About

Mabion SA is a Poland-based company engaged in the research and development of biotechnological and biopharmaceutical medicinal products. Mabion SA was founded by four pharmaceutical companies, including Celon Pharma Ltd, Polfarmex Co, Genexo Ltd and IBSS Biomed Co, as well as two companies focused on research and development in... (more)

Overall

Beta: 0.80
Market Cap(Mil.): zł1,233.10
Shares Outstanding(Mil.): 11.80
Dividend: --
Yield (%): --

Financials

  MABP.WA Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -4.82 -- --
ROI: -64.66 1.79 14.61
ROE: -99.15 3.28 16.33

BRIEF-Mabion Q2 Net Loss Widens To 26.8 Mln Zlotys

* REPORTED ON THURSDAY Q2 NET LOSS OF 26.8 MLN ZLOTYS VS LOSS 12.5 MLN ZLOTYS YEAR AGO

14 Sep 2018

BRIEF-EBRD Buys 5.72% Stake Of Mabion

* EUROPEAN BANK FOR RECONSTRUCTION AND DEVELOPMENT (EBRD) BUYS ABOUT 5.72% STAKE IN CO IN SHARES ACQUISITION TRANSACTION

27 Mar 2018

Earnings vs. Estimates